Gene Therapy in Hemophilia A: Safety, Efficacy, and the Changing Landscape

Atta Chowdhry, RPh, and Robert Sidonio Jr, MD, MSc, discuss the safety and efficacy of gene therapy for hemophilia A, highlighting recent approvals, with insights into adverse effects, immunosuppression, and the evolving treatment landscape.

Related Keywords

Jonathan Ogurchak ,Robert Sidonio Jr ,Atta Chowdhry , ,Gene Therapy ,Hemophilia A ,Roctavian ,Safety ,Efficacy ,Immunosuppressive Therapy ,Factor Products ,Hemophilia Community ,Neutralizing Antibodies ,Annualized Bleed Rate ,Treatment Landscape ,Treatment Options ,Bleeding Episodes ,